Gemcitabine–cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward
Authors:
- 21 March 2018
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 35 (4) , 57
Abstract
Data on adjuvant chemotherapy with gemcitabine–cisplatin (GC) in resected gallbladder cancers (GBC) are scarce. Patients who underwent upfront curative resection for GBC from 2010 to 2016 were analyzed. Patients with stage II–III GBC treated with adjuvant GC were analyzed. A total of 242 patients were evaluated, of whom 125 patients received GC regimen as adjuvant chemotherapy. The median age was 50 years (range 31–74), majority were female (77.6%), and 37 patients (29.6%) had raised CA 19.9 levels at baseline. One hundred and thirteen patients (90.4%) underwent radical cholecystectomy with R0 resections. Median number of GC administered was 6, with completion rates of 84%. Toxicity data were comprehensively available for 110 patients, with common grade 3 and grade 4 being neutropenia (9.9%), fatigue (7.3%) and febrile neutropenia (3.6%), respectively. With a median follow-up of 36.88 months, 3-year RFS was 60.3%. Patients with stage II (28%; n = 35), stage IIIA (28%; n = 35) and stage IIIB GBC (44%; n = 55) had a 3-year OS of 91.9, 67 and 58.1% (p = 0.001), respectively. Patients with stage II–III GBC undergoing R0 resections receiving adjuvant GC have good tolerance, high completion rates and encouraging outcomes in a non-trial high GBC prevalence scenario.Keywords
This publication has 24 references indexed in Scilit:
- Patterns of recurrence after resection of gallbladder cancer without routine extrahepatic bile duct resectionHPB, 2014
- Genetics of Biliary Tract Cancers and Emerging Targeted TherapiesJournal of Clinical Oncology, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignanciesHPB, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II studyBritish Journal of Cancer, 2008
- Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trialsBritish Journal of Cancer, 2007
- Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata Memorial HospitalJournal of Cancer Research and Therapeutics, 2006
- Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinomaCancer, 2003
- Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?Cancer, 2002